CellarisBio is a drug discovery platform focused on cellular target engagement. Our Micro-tag technology enables discovery, validation and optimization of novel therapeutics to challenging drug targets in the physiological environment of the cell. We tackle challenging targets such as transcription factors, membrane proteins and enzymes. We focus therapeutic modalities such as small molecules, Protacs, peptides and antibodies.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 9276 Scranton Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cellarisbio.com
- Keywords
- Los Angeles.
- HQ
- San Diego, California
Cellarisbio Questions
Cellarisbio's website is http://www.cellarisbio.com
Cellarisbio's LinkedIn profile is https://www.linkedin.com/company/cellarisbio
Cellarisbio has
5 employees.
View email and phone details for 5
employees at Cellarisbio.
Cellarisbio's industry is
Biotechnology Research
Cellarisbio's top competitors are
Cellaris Therapeutics,
Cellics Therapeutics, Inc.,
Zafrens,
Biolabs San Diego,
Cellares,
Brainstorm Therapeutics, Inc.,
Bluebridge,
Nimbus Therapeutics,
Defined Bioscience,
Probius.
Cellarisbio's categories are Biotechnology Research
Cellarisbio's founding year is 2018
